Zimmer Biomet (ZBH) PT Raised to $130 at Cowen as Company Commentary Indicates Consensus is Too Low
Tweet Send to a Friend
Cowen analyst Joshua Jennings raised the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $116.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
